Inventiva (IVA) Operating Leases (2022 - 2025)
Inventiva (IVA) recorded quarterly Operating Leases of $3.3 million in Q4 2025, down 28.5% quarter-over-quarter from $4.6 million in Q2 2025, and up 21.04% on a YoY basis from $2.7 million in Q4 2024.
Inventiva (IVA) Operating Leases (2022 - 2025) Analysis & Trends
Inventiva's Operating Leases history runs 4 years deep, the most recent figure standing at $3.3 million for Q4 2025.
- In Q4 2025, Operating Leases rose 21.04% year-over-year to $3.3 million; the TTM figure through Dec 2025 stood at $3.3 million (up 21.04% YoY), while the FY2025 annual figure was $3.3 million, up 21.04% from the prior year.
- Operating Leases was $3.3 million for Q4 2025 at Inventiva, down from $4.6 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $7.1 million in Q2 2024 to a low of $2.7 million in Q4 2024.
- Historically, Operating Leases has averaged $4.6 million across 4 years, with a median of $4.6 million in 2023.
- Biggest YoY gain for Operating Leases was 31.64% in 2024; the steepest drop was 41.35% in 2024.
- A 4-year view of Operating Leases shows it stood at $4.6 million in 2022, then slipped by 0.22% to $4.6 million in 2023, then sank by 41.35% to $2.7 million in 2024, then gained by 21.04% to $3.3 million in 2025.
- The last three Operating Leases figures came in at $3.3 million (Q4 2025), $4.6 million (Q2 2025), and $2.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.26 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Jun 30, 2024 | 7.07 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Jun 30, 2023 | 5.37 Mn |
| Dec 31, 2022 | 4.60 Mn |